Recce Pharmaceuticals Ltd.ASX: RCE

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by Recce Pharmaceuticals Ltd. via ASX

Filed with ASX ·

ASX Announcement Quarterly Cash Flow Statement & Operational Highlights Highlights: • HREC approves active controlled comparator study design for pivotal Phase 3 ® clinical trial of RECCE 327 Topical Gel (R327G) in Diabetic Foot Infections (DFI) in Australia ® • Vietnamese patent granted for...

View Attachment

6ix is reading this filing.

Recce Pharmaceuticals Ltd. on 6ix

Earlier from Recce Pharmaceuticals

All Recce Pharmaceuticals news releases